CAFE

◈주식일정 / 시황

오늘의 주요 종목 뉴스

작성자안나푸르나|작성시간24.08.21|조회수128 목록 댓글 0

"이 정도로 지지율이 급등하는 건 내 평생 처음 봤다"

https://www.ohmynews.com/NWS_Web/Series/series_premium_pg.aspx?CNTN_CD=A0003054616

[우리바이오, 오성첨단소재, 일신석재, 애머릿지, 인디에프, 현대약품, 명문제약 등]

 

 

인텍플러스, '전세계 1위' 파운드리와 기판 검사장비 공급계약 체결

https://zdnet.co.kr/view/?no=20240820154901

[인텍플러스]

 

 

유한양행 '렉라자' 美 FDA 승인…국산 항암제로 처음

https://www.chosun.com/economy/science/2024/08/20/NHFT76XYMYIJIC6GBWD4NTC2QY/

[오스코텍, 유한양행]

 

 

커지는 전기차 포비아...K전고체 배터리 날까 [이코노株인공]

https://economist.co.kr/article/view/ecn202408200058

[이렘, 한농화성, 이수스페셜티, 씨아이에스, 레몬 등]

 

 

코로나 증상에도 검사않고 출근·등교…"숨은감염 우려"

https://www.newsis.com/view/NISX20240820_0002856330

[일신바이오, 메디아나, 대한과학, 멕아이씨에스, 서린바이오, 랩지노믹스, 씨젠, 휴마시스 등]

 

 

엠폭스(원숭이두창) 검역감염병 재지정...관련주 또 오를까

https://www.gukjenews.com/news/articleView.html?idxno=3070542

[우정바이오, 파미셀. 케스피온, 미코바이오메드 등]

 

 

SK바이오팜·셀트리온…"제2 렉라자는 우리 것"

https://www.hankyung.com/article/2024082046831

[SK바이오팜, 셀트리온 등]

 

현대약품, 개량신약 복합제 임상 3상 승인 신청 

https://www.bloter.net/news/articleView.html?idxno=621702

[현대약품]

 

 

"-67%, 더는 못 버텨" 개미들은 털었는데…반대로 가는 외인·기관

https://news.mt.co.kr/mtview.php?no=2024082016384234179&cast=1&STAND=MT_T

[에코프로 등]

 

 

[미코바이오메드]

 

 

SKC, 불성실공시법인 미지정…주의 조치

https://view.asiae.co.kr/article/2024082017425210172

[SKC]

 

 

Fed 금리인하 기대 고조에…골드바 최고가, 달러는 약세

https://www.joongang.co.kr/article/25271810

[엘컴텍 등]

 

 

HD현대인프라, 중동 공략 가속…사우디서 건설 장비 대량 수주

https://www.hankyung.com/article/2024082046811

[HD현대인프라코어]

 

 

한미반도체, 'TC 본더' 앞세워 수익성 극대화...하반기는 더 좋다

https://www.bloter.net/news/articleView.html?idxno=621712

[한미반도체]

 

 

전시차 없이 일주일 새 본계약 1.3만건…액티언 '흥행 돌풍' [biz-플러스]

https://www.sedaily.com/NewsView/2DD3PSBCCJ/GD01

[KG모빌리티]

 

 

롯데월드 통째 빌릴 만했네…960억 미사일로 9조 번 회사

https://www.joongang.co.kr/article/25271799

[LIG넥스원]

 

 

아이티센, 일본토큰증권협회 합류...글로벌 시장 활성화 지원

https://www.mk.co.kr/news/economy/11097236

[아이티센]

 

 

한세예스24, 車부품사업 진출…이래AMS 인수 우협대상자 선정

https://www.edaily.co.kr/News/Read?newsId=03342326638989288&mediaCodeNo=257

[한세예스24홀딩스]

 

 

與 “회담 생중계로 민생 법안 논의” vs 野 “‘제보공작 의혹도 수사’ 수용”

https://www.donga.com/news/Politics/article/all/20240820/126605263/1

[단독] 與원로들, 韓 만나 "머리는 검증됐지만 가슴은 검증 필요"

https://www.chosun.com/politics/2024/08/20/KHWHWPWTOVCJNGNJLZSSLYF3GU/

민주당 "친일 반민족 행위 찬양하면 공직 불가" 입법 추진

https://www.joongang.co.kr/article/25271814

화천기계, 삼보산업, 대상홀딩스, 디티앤씨알오, 태양금속, 동신건설, 써니전자, PN풍년, 진양폴리,

신라에스지, 래몽래인, KNN, 티비씨, 국영지앤엠 등]

 

 

SK네트웍스, SK렌터카 지분 매각 완료

https://www.etnews.com/20240820000336

[SK네트웍스]

 

 

삼성SDS “AI 전략 공유” 내달 3일 ‘리얼 서밋’ 개최

https://www.donga.com/news/Economy/article/all/20240820/126608331/2

[삼성SDS]

 

 

“붕어빵 대신 베트남 전래동화 봉방~” 제품명도 맛도 현지에 맞춤… 식품업계, 내수 부진 딛고 해외서 해답

https://www.kmib.co.kr/article/view.asp?arcid=0020439624&code=61141611&sid1=eco

[오리온, 롯데웰푸드 등]

 

 

뜨거운 택배전쟁…CJ대한통운 주7일 배달한다, 쿠팡에 맞불

https://www.joongang.co.kr/article/25271978

[CJ대한통운]

 

 

아모레 '헤라', 태국에 첫 깃발…방콕 쇼핑 중심지

https://www.sedaily.com/NewsView/2DD3ATK2Z0/GD02

[아모레퍼시픽]

 

 

이복현 "우리금융 행태, 더 이상 신뢰하지 못할 수준"

https://www.chosun.com/economy/economy_general/2024/08/20/LDB5N5MBUVBV7LNPVXJ4BQSY5Y/

[우리금융]

 

 

K-배터리 3사 BMS 특허건수, 중국·일본 앞서…LG엔솔이 견인

https://stock.mk.co.kr/news/view/515953

[LG에너지솔루션]

 

 

SK하이닉스, 日 키옥시아 또 평가손실…투자금 회수 '고민'

https://www.bloter.net/news/articleView.html?idxno=621690

[SK하이닉스]

 

 

LG전자 '새 먹거리' 잘나가더니…'매출 반토막' 무슨 일이? [김채연의 IT말아먹기]

https://www.hankyung.com/article/202408204097i

[LG전자]

 

 

AMD, 또 6.5조원 M&A…파트너 삼성도 웃는다

https://www.joongang.co.kr/article/25271923

[삼성전자]

 

 

현대차그룹, 1∼7월 미국 전기차 시장 점유율 2위…포드 · GM 앞섰다

https://news.sbs.co.kr/news/endPage.do?news_id=N1007769607

다음검색
현재 게시글 추가 기능 열기

댓글

댓글 리스트
맨위로

카페 검색

카페 검색어 입력폼